From: Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?
Effectiveness
Survival benefit > 3 months
Survival benefit < 3 months, unknown magnitude or no benefit
Total
ESMO-score
Score A, B, 5 or 4
3
0
Score C, 1, 2 or 3
4
7
6
10